Bladder cancer
194 results
1 - 100Bladder cancer
Bladder cancer (ultrasonography) - Image
Pioglitazone exposure increases bladder cancer risk
Adjuvant chemotherapy for invasive bladder cancer
Neo‐adjuvant chemotherapy for invasive bladder cancer
Neoadjuvant chemotherapy for invasive bladder cancer
Bladder cancer screening: insufficient evidence to recommend (USPSTF)
Neoadjuvant cisplatin for advanced bladder cancer: Cochrane systematic review
Surgery versus radiotherapy for muscle invasive bladder cancer
Adjuvant chemotherapy for invasive bladder cancer (individual patient data)
Surgery versus radiotherapy for muscle invasive bladder cancer
Intravesical Bacillus Calmette‐Guérin in Ta and T1 bladder cancer
Intravesical Bacillus Calmette‐Guérin versus epirubicin for Ta and T1 bladder cancer
Intravesical gemcitabine for non‐muscle invasive bladder cancer
Intravesical BCG and antineoplastic agents in Ta and T1 bladder cancer
En‐bloc resection versus conventional transurethral resection for patients with non‐muscle‐invasive bladder cancer
Blue versus white light for transurethral resection of non‐muscle invasive bladder cancer
Intravesical gemcitabine for non-muscle invasive bladder cancer
Intravesical bacillus Calmette-Guerin versus mitomycin C for bladder cancer.
Selenium not helpful for patients with bladder cancer; vitamin E may be harmful
Intravesical electromotive drug administration for non‐muscle invasive bladder cancer
Intravesical Bacillus Calmette‐Guérin versus mitomycin C for Ta and T1 bladder cancer
Gemcitabine for unresectable, locally advanced or metastatic bladder cancer: Cochrane systematic review
Perioperative nutrition for the treatment of bladder cancer by radical cystectomy
Narrow band imaging versus white light cystoscopy alone for transurethral resection of non‐muscle invasive bladder cancer
Postoperative interventions for preventing bladder dysfunction after radical hysterectomy in women with early‐stage cervical cancer
Robotic versus open radical cystectomy for bladder cancer in adults
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Cochrane systematic review
Intravesical Bacillus Calmette‐Guérin with interferon‐alpha versus intravesical Bacillus Calmette‐Guérin for treating non‐muscle‐invasive bladder cancer
Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy
Single‐dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma